6660 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. Its products include Recombinant hepatitis B vaccine, Freeze-dried Human Rabies vaccine, Inactivated Hepatitis A vaccine, Live Attenuated Parotitis vaccine, Inactivated HFRS vaccine, and ACYW135 Meningococcus Polysaccharide vaccine. The company was founded on November 9, 2011 and is headquartered in Beijing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6660 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company